SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-126873
Filing Date
2023-12-18
Accepted
2023-12-18 16:16:05
Documents
13
Period of Report
2023-12-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332524d2_8k.htm   iXBRL 8-K 26286
2 EXHIBIT 3.1 tm2332524d2_ex3-1.htm EX-3.1 158777
  Complete submission text file 0001104659-23-126873.txt   398214

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rytm-20231214.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20231214_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20231214_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2332524d2_8k_htm.xml XML 3421
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 231493925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)